Similar articles for PMID: 22179836

Year	Number of Results
2000	1
2004	4
2005	1
2006	2
2007	4
2008	2
2009	7
2010	8
2011	11
2012	14
2013	7
2014	4
2015	5
2016	11
2017	5
2018	3
2019	3
2020	2
2021	3
2022	4
2023	1
2024	0

1

Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish.

Camus S, Quevedo C, Menéndez S, Paramonov I, Stouten PF, Janssen RA, Rueb S, He S, Snaar-Jagalska BE, Laricchia-Robbio L, Izpisua Belmonte JC. Camus S, et al. Oncogene. 2012 Sep 27;31(39):4333-42. doi: 10.1038/onc.2011.594. Epub 2011 Dec 19. Oncogene. 2012. PMID: 22179836

2

Mammalian tumor xenografts induce neovascularization in zebrafish embryos.

Nicoli S, Ribatti D, Cotelli F, Presta M. Nicoli S, et al. Cancer Res. 2007 Apr 1;67(7):2927-31. doi: 10.1158/0008-5472.CAN-06-4268. Cancer Res. 2007. PMID: 17409396 Free article.

3

Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.

Tran TC, Sneed B, Haider J, Blavo D, White A, Aiyejorun T, Baranowski TC, Rubinstein AL, Doan TN, Dingledine R, Sandberg EM. Tran TC, et al. Cancer Res. 2007 Dec 1;67(23):11386-92. doi: 10.1158/0008-5472.CAN-07-3126. Cancer Res. 2007. PMID: 18056466

4

Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.

Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT. Zhong ZF, et al. J Ethnopharmacol. 2012 Jun 1;141(2):721-7. doi: 10.1016/j.jep.2011.08.052. Epub 2011 Sep 3. J Ethnopharmacol. 2012. PMID: 21911050

5

Antiangiogenic cancer drug using the zebrafish model.

Santoro MM. Santoro MM. Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1846-53. doi: 10.1161/ATVBAHA.114.303221. Epub 2014 Jun 5. Arterioscler Thromb Vasc Biol. 2014. PMID: 24903092 Review.

6

TGF-β1 enhances tumor-induced angiogenesis via JNK pathway and macrophage infiltration in an improved zebrafish embryo/xenograft glioma model.

Yang XJ, Chen GL, Yu SC, Xu C, Xin YH, Li TT, Shi Y, Gu A, Duan JJ, Qian C, Cui YH, Zhang X, Bian XW. Yang XJ, et al. Int Immunopharmacol. 2013 Feb;15(2):191-8. doi: 10.1016/j.intimp.2012.12.002. Epub 2012 Dec 21. Int Immunopharmacol. 2013. PMID: 23261760

7

Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.

Dutour A, Rigaud M. Dutour A, et al. Anticancer Res. 2005 Nov-Dec;25(6B):3799-807. Anticancer Res. 2005. PMID: 16309166 Free article. Review.

8

A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.

Evensen L, Micklem DR, Link W, Lorens JB. Evensen L, et al. Cytometry A. 2010 Jan;77(1):41-51. doi: 10.1002/cyto.a.20808. Cytometry A. 2010. PMID: 19834964 Free article.

9

Modelling approaches for angiogenesis.

Taraboletti G, Giavazzi R. Taraboletti G, et al. Eur J Cancer. 2004 Apr;40(6):881-9. doi: 10.1016/j.ejca.2004.01.002. Eur J Cancer. 2004. PMID: 15120043 Review.

10

Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.

Bagley RG, Rouleau C, Weber W, Mehraein K, Smale R, Curiel M, Callahan M, Roy A, Boutin P, St Martin T, Nacht M, Teicher BA. Bagley RG, et al. Microvasc Res. 2011 Nov;82(3):253-62. doi: 10.1016/j.mvr.2011.09.004. Epub 2011 Sep 17. Microvasc Res. 2011. PMID: 21958527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year